Pakistan Science Abstracts
Article details & metrics
No Detail Found!!
The effect of Pamidronate on Bone Mineral Density in Primary Osteoporosis in Pakistani Population.
Author(s):
1. Waseem Afzal: Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
2. Saima Manzoor: Yusra Medical & Dental College Islamabad Pakistan
3. Khadija Mehboob: Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Abstract:
Objective: To study the protective effect of Bisphosphonates (Pamidronate) in patients of primary osteoporosis in Pakistani setup. Study Design: Quasi experimental study. Place and Duration of Study: The study was carried out at department of orthopedic and spine surgery, CMH Rawalpindi, from Sep 2011 to Sep 2013. Material and Methods: A non probability convenience sample was collected from 50 patients who visited orthopaedics department with complaints of generalized aches and pains and diagnosed to have primary osteoprosis. Osteoporosis was confirmed by DEXA scan, with a T-score of more than -2.5. Pamidronate-a bisphosphonate, was given I/V on monthly basis along with oral calcium. After 6 month and one year DEXA scan was repeated to observe its effect on bone mineral density Results: Osteoporosis T score of DEXA scan was seen to improve by 19.3% (0.193 T score improvement) with a p-value less than 0.05. Conclusion: Pamidronate treatment increased bone mineral density in osteoprotic patients.
Page(s): 502-505
DOI: DOI not available
Published: Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 3, Year: 2018
Keywords:
Osteoporosis
References:
[1] .The 2008 Revision Population Database, -
[2] 2009.Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis,Clinical intervention in aging 4 207 -14
[3] NayakS,RobertsMS,GreenspanSL, 2011.Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women,Ann Intern Med 155 751 -61
[4] MajumdarSR,LierDA,BeaupreLA,HanleyDA,MaksymowychWP,JubyAG, 2009.Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial,Arch Intern Med 169 25 -31
[5] DrakeMT,ClarkeBL,KhoslaS.,Bisphosphonates, 2008.: mechanism of action and role in clinical practice,Mayo Clin Proc 83 1032 -
[6] Van BeekE,CohenL,LeroyI,EbetinoE,LowikC, 2003.Papapoulos S. Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates,Bone 33 805 -11
[7] EriksenEF,Díez-PérezA,BoonenS, January 2014."Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review",Bone 58 126 -35
[8] WhitakerM,GuoJ,KehoeT,BensonG, 2048.Bisphosphonates for osteoporosis--where do we go from here,N Engl J Med 366 -
[9] GenantHK,EngelkeK,FuerstT,GlüerCC,GramppS,HarrisST, 1996.Noninvasive assessment of bone mineral and structure: state of the art,J Bone Miner Res 11 707 -30
[10] EekmanDA,VisM,BultinkIE,DerikxHJ,DijkmansBA,LemsWF, 2009.Treatment with intravenous pamidronate is a good alternative incase of gastrointestinal side effects or contraindications for oral bisphosphonates,BMC Musculoskeletal Disorders 10 86 -
[11] HeijckmannAC,JuttmanJR,WolffenbuttelBH, 2002.Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis,Neth J Med 60 315 -9
[12] PeretzA,BodyJJ,DumonJC,RozenbergS,HotimskiA,PraetJP, 1996.Cyclical pamidronate infusions in post-menopausal osteoporosis,Maturitas 25 69 -75
[13] WilkinsonJM,StockleyI,PeelNF,HamerAJ,ElsonRA,BarringtonNA, 2001.Effect of pamidronate in preventing local bone loss after total hip arthroplasty: A randomized, doubleblind, controlled trial,J Bone Miner Res 16 556 -64
[14] MenzdorfL,WeusterM,KlüterT,BrüggemannS,BehrendtP,Fitchen-OesternS, 2016.Local pamidronate influences fracture healing in a rodent femur fracture model: An experimental study,BMC Musculoskeletal Disorders 17 255 -
[15] NagiD,ButtZ,FarooqF,AamarA, 2013.Frequency of osteoporosis in an ambulatory setting in Lahore using quantitative calcaneal ultrasound,J Pak Med Assoc 63 965 -8
Citations
Citations are not available for this document.
0

Citations

0

Downloads

4

Views